Lallemand Animal Nutrition
United Kingdom & Ireland - English   [ change ]
Our R&D process

Our research and development process spans from discovery to customer use. We operate a three-step discovery process based on a wide array of technologies and skills, evolving towards molecular microbiology and omics techniques.

1. Discovery and proof of concept:

  • Strain screening and selection
    • Functional assays
    • Lallemand Aquapharm screening platform
    • >12,500 strains
    • Ecosystem-specific microbial collections
  • Strain characterization and safety
    • Strain identity: whole-genome sequencing
    • Antibiotic-resistant genes, presence of mobile genetic elements
    • Microbial fractions characterization
    • Functional properties
  • Development of models and methods
    • Functional microarrays
    • Quantitative real-time PCR
    • Dynamic in vitro models
    • Diverse type of biomarkers
  • In vitro/in vivo proof of concept
    • Proof of concept animal and silage trials
  • Mini silos trials for forage inoculants

2. Scale-up and registration

  • Production scale-up, process optimization
    • Internal process optimization and scale-up team
    • Internal pilot plants
    • State of the art analytical tools: cytometry, cryomicroscopy, differential scanning calorimetry (DSC)
  • Product stability and applicability
    • Product formulation optimization
    • Internal pilot feed processing unit
    • Strain and matrix specific analytical methods
    • Next generation microbial cell counters
  • In vivo efficacy assessment
    • Strong collaboration network with research partners to conduct efficacy trials in all livestock species (ruminant, swine, poultry, aquaculture…), companion animals and equine.
    • Dedicated large experimental bunker units for forage inoculants
  • Products registration
    • Dedicated team of territory specific specialists for the preparation of regulatory dossiers

3. Product Deployment

  • Modes of action investigation to strengthen product documentation
    • Focus on the role of our solutions on microbial ecosystems and associated impact on animal response, such as performance, welfare, immunity, oxidative stress, metabolism etc.
    • Controlled in vitro, ex vivo and in vivo studies to understand modes of action for strains in order to optimize and extend applications
    • Application of novel biomarkers and sensors to assess products effects beyond animal performance (e.g. animal welfare)
  • Applied trials
    • Controlled large scale trials
    • Pilot farms network in ruminants, swine, poultry, and aquaculture
  • Development of audit tools and on-farm services